These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20102602)

  • 1. Inactivation of respiratory syncytial virus by zinc finger reactive compounds.
    Boukhvalova MS; Prince GA; Blanco JC
    Virol J; 2010 Jan; 7():20. PubMed ID: 20102602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats.
    Kamphuis T; Stegmann T; Meijerhof T; Wilschut J; de Haan A
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1227-36. PubMed ID: 23575113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
    Arthur LO; Bess JW; Chertova EN; Rossio JL; Esser MT; Benveniste RE; Henderson LE; Lifson JD
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S311-9. PubMed ID: 9814959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
    Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.
    Chertova E; Crise BJ; Morcock DR; Bess JW; Henderson LE; Lifson JD
    Curr Mol Med; 2003 May; 3(3):265-72. PubMed ID: 12699362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.
    Patton K; Aslam S; Shambaugh C; Lin R; Heeke D; Frantz C; Zuo F; Esser MT; Paliard X; Lambert SL
    Vaccine; 2015 Aug; 33(36):4472-8. PubMed ID: 26206269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico structure-based design and synthesis of novel anti-RSV compounds.
    Cancellieri M; Bassetto M; Widjaja I; van Kuppeveld F; de Haan CA; Brancale A
    Antiviral Res; 2015 Oct; 122():46-50. PubMed ID: 26259810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.
    Lee Y; Ko EJ; Kim KH; Lee YT; Hwang HS; Jung YJ; Jeeva S; Kwon YM; Seong BL; Kang SM
    Antiviral Res; 2019 Aug; 168():100-108. PubMed ID: 31150678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.
    Boukhvalova MS; Prince GA; Soroush L; Harrigan DC; Vogel SN; Blanco JC
    Vaccine; 2006 Jun; 24(23):5027-35. PubMed ID: 16675071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.
    Russell MS; Creskey M; Muralidharan A; Li C; Gao J; Chen W; Larocque L; Lavoie JR; Farnsworth A; Rosu-Myles M; Hashem AM; Yauk CL; Cao J; Van Domselaar G; Cyr T; Li X
    Front Immunol; 2019; 10():597. PubMed ID: 30984178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X; Zhou H; Tang RS; Munoz MG; Jin H
    Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
    Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.
    Boukhvalova MS; Yim KC; Blanco J
    Antivir Chem Chemother; 2018; 26():2040206618770518. PubMed ID: 29768937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.